Details for New Drug Application (NDA): 018535
✉ Email this page to a colleague
NDA 018535 describes DIULO, which is a drug marketed by Gd Searle Llc and is included in one NDA. Additional details are available on the DIULO profile page.
The generic ingredient in DIULO is metolazone. There are ten drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the metolazone profile page.
The generic ingredient in DIULO is metolazone. There are ten drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the metolazone profile page.
Summary for 018535
| Tradename: | DIULO |
| Applicant: | Gd Searle Llc |
| Ingredient: | metolazone |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018535
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 2.5MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
